These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10737290)

  • 1. Troglitazone-induced pulmonary edema.
    Inoue K; Sano H
    Arch Intern Med; 2000 Mar; 160(6):871-2. PubMed ID: 10737290
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary edema associated with troglitazone therapy.
    Hirsch IB; Kelly J; Cooper S
    Arch Intern Med; 1999 Aug 9-23; 159(15):1811. PubMed ID: 10448787
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatic injury due to troglitazone.
    Malik AH; Prasad P; Saboorian MH; Thiele DL; Malet PF
    Dig Dis Sci; 2000 Jan; 45(1):210-4. PubMed ID: 10695637
    [No Abstract]   [Full Text] [Related]  

  • 4. Advisory panel hears contradictory evidence, backs keeping troglitazone on market.
    Miller JL
    Am J Health Syst Pharm; 1999 May; 56(9):840, 842. PubMed ID: 10344603
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary edema associated with rosiglitazone and troglitazone.
    Thomas ML; Lloyd SJ
    Ann Pharmacother; 2001 Jan; 35(1):123-4. PubMed ID: 11197573
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA reviews troglitazone.
    Donnelly R
    Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513
    [No Abstract]   [Full Text] [Related]  

  • 7. Deterioration of rheumatoid arthritis with troglitazone: a rare and unexpected adverse effect.
    Sakurai A; Hashizume K
    Arch Intern Med; 2000 Jan; 160(1):118-9. PubMed ID: 10632316
    [No Abstract]   [Full Text] [Related]  

  • 8. The rise and fall of troglitazone.
    Bailey CJ
    Diabet Med; 2000 Jun; 17(6):414-5. PubMed ID: 10975209
    [No Abstract]   [Full Text] [Related]  

  • 9. Update in endocrinology.
    Whitcomb RW
    Ann Intern Med; 1998 May; 128(10):871. PubMed ID: 9599203
    [No Abstract]   [Full Text] [Related]  

  • 10. How should patients taking the discontinued diabetes drug troglitazone be managed?
    Reddy SS
    Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion from troglitazone to rosiglitazone.
    Bell DS; Ovalle F; Shadmany S
    Endocr Pract; 2001; 7(4):326. PubMed ID: 11497487
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.
    King AB
    Diabetes Care; 2000 Apr; 23(4):557. PubMed ID: 10857952
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel antidiabetic drug, troglitazone--reason for hope and concern.
    Imura H
    N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical results of troglitazone (CS-045)].
    Iwamoto Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():131-6. PubMed ID: 9434456
    [No Abstract]   [Full Text] [Related]  

  • 15. The polycystic ovary syndrome: treatment with insulin sensitizing agents.
    Iuorno MJ; Nestler JE
    Diabetes Obes Metab; 1999 May; 1(3):127-36. PubMed ID: 11220291
    [No Abstract]   [Full Text] [Related]  

  • 16. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin sensitizers for polycystic ovary syndrome.
    Baillargeon JP; Iuorno MJ; Nestler JE
    Clin Obstet Gynecol; 2003 Jun; 46(2):325-40. PubMed ID: 12808383
    [No Abstract]   [Full Text] [Related]  

  • 18. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
    Krentz AJ; Bailey CJ; Melander A
    BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
    [No Abstract]   [Full Text] [Related]  

  • 19. [Insulin-sensitizing agent].
    Yamanouchi T
    Nihon Rinsho; 1999 Mar; 57(3):675-80. PubMed ID: 10199153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone use in polycystic ovary syndrome.
    Landman RE; Jacobs TP
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5090-1. PubMed ID: 11600596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.